What we do
Ipsen is a leading biopharmaceutical group dedicated to improving lives through innovative medicines in oncology, neuroscience and rare diseases.
Our therapeutic areas
We achieve our goal of improving lives through close collaboration with
patient organizations, patients, caregivers, nurses, physicians, and
communities on a local and global level.
Ipsen has a specialist portfolio in niche oncology. We have been active in this area since 1986, branching out from a solid base in neuroendocrine tumors (NETs), kidney, liver, pancreatic, prostate, bladder, and breast cancers.
Ipsen continues its long-standing commitment to a multi-modal approach to treating mobility impairment in adult and pediatric patients and improving their quality of life.
In the field of rare diseases, Ipsen takes a patient-focused approach to improving the lives of people affected by rare disorders and develops high-quality, innovative treatments that address unmet needs.
Ipsen’s long-standing expertise spans the value chain, with special expertise in gastrointestinal (GI) disorders, neurodegenerative pathologies and rheumatology, as well as a constantly expanding portfolio.
2019 Annual Report
With our most robust R&D pipeline yet, continued financial growth and the execution of our first materiality matrix assessment for CSR, 2019 was a record year for Ipsen.Explore Our 2019 Digital Annual Report
Careers at Ipsen
Ipsen offers exciting opportunities that will challenge your abilities , expand your skills and reward your contribution in a positive atmosphere of personal and professional development.Search Ipsen positions
Research & Development
Ipsen’s commitment to research & development is our bold promise to patients to launch at least one new drug or meaningful new indication every year. We will secure our future by building a pipeline of innovative medicines.
Research & Development
By partnering with Ipsen, you will gain access to a like-minded global biopharmaceutical company with powerhouse development and commercialization teams.
As a global pharmaceutical company with a biotech mindset and a proven ability to provide new, life-changing therapies, Ipsen is a leading player in its core therapeutic areas.